INDOLENT LYMPHOMA
Clinical trials for INDOLENT LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new INDOLENT LYMPHOMA trials appear
Sign up with your email to follow new studies for INDOLENT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail targets Tough-to-Treat lymphoma
Disease control Not yet recruitingThis study tests a combination of two drugs, pomalidomide and obinutuzumab, in people with slow-growing lymphomas (like follicular lymphoma) that have not responded to or returned after previous treatment. The first part finds the safest dose, and the second part checks how well …
Matched conditions: INDOLENT LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 08:39 UTC
-
New pill shows promise for Hard-to-Treat lymphomas
Disease control Not yet recruitingThis study tests a daily pill called lisaftoclax (APG-2575) in 75 adults with slow-growing lymphomas (CLL, WM, or MZL) who cannot take or have stopped responding to standard treatments. The goal is to see if the drug is safe and can shrink or control the cancer. Participants take…
Matched conditions: INDOLENT LYMPHOMA
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated May 19, 2026 11:47 UTC